Here are five things to know about the shortage.
1. All commercially available sizes of sterile water, ranging from 5 milliliters to 100 milliliters, are on back order. Resupply dates span from late January to March.
2. Pfizer, a major manufacturer of sterile water for injections, cited manufacturing delays as the cause of low production levels. Another large manufacturer, Fresenius Kabi, cited increased demand as the reason for the shortage.
3. The shortage has boosted demand for larger sterile injection bags (250 milliliters to 3,000 milliliters), which have also experienced intermittent shortages.
4. Hospitals use sterile water for injection vials to reconstitute medications available in powder form. When supplies are low, clinicians must either administer a different medication or use a different sterile liquid to mix with the drug, “despite a lack of definite information about the effects on drug stability and compatibility,” according to ASHP.
5. ASHP is working with the University of Utah Drug Information Service, the FDA and other stakeholders to learn more about the shortage and develop strategies to mitigate it.
Editor’s note: This article was updated Feb. 5 to include additional information.
More articles on supply chain:
10 most-read supply chain stories in January
FDA approves record number of personalized medicines in 2017: 4 things to know
FDA approves treatment for C. diff-associated diarrhea: 3 things to know
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
